Xvivo Perfusion AB (publ)
XVIPY · OTC
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Operating Activities | – | – | – | – |
| Net Income | $172 | $92 | $22 | $7 |
| Dep. & Amort. | $67 | $31 | $42 | $32 |
| Deferred Tax | $0 | $0 | -$7 | -$3 |
| Stock-Based Comp. | $7 | $2 | $0 | $3 |
| Change in WC | -$79 | -$39 | -$22 | -$23 |
| Other Non-Cash | -$56 | -$39 | -$14 | -$28 |
| Operating Cash Flow | $111 | $46 | $28 | -$12 |
| Investing Activities | – | – | – | – |
| PP&E Inv. | -$71 | -$43 | -$131 | -$94 |
| Net Acquisitions | -$50 | -$18 | -$67 | -$93 |
| Inv. Purchases | $0 | $0 | $179 | -$0 |
| Inv. Sales/Matur. | $0 | $0 | $1 | $84 |
| Other Inv. Act. | -$123 | -$101 | -$179 | -$84 |
| Investing Cash Flow | -$244 | -$162 | -$198 | -$188 |
| Financing Activities | – | – | – | – |
| Debt Repay. | -$11 | $0 | $0 | -$6 |
| Stock Issued | $0 | $429 | $1 | $245 |
| Stock Repurch. | $0 | $0 | -$0 | $0 |
| Dividends Paid | $0 | $0 | $0 | $0 |
| Other Fin. Act. | $0 | -$11 | -$7 | -$5 |
| Financing Cash Flow | -$11 | $419 | -$7 | $235 |
| Forex Effect | $13 | -$4 | $24 | $10 |
| Net Chg. in Cash | -$131 | $300 | -$152 | $44 |
| Supplemental Information | – | – | – | – |
| Beg. Cash | $546 | $247 | $399 | $354 |
| End Cash | $416 | $546 | $247 | $399 |
| Free Cash Flow | $41 | -$98 | -$103 | -$106 |